All you need to know about TMB Pre-IPO shares

Some of our investors first invested in TMB Pre-IPO Shares at around Rs. 220/share on Feb’2018, and since then, here is how the price graph has moved: Jan 2019 – Rs. 320/share Nov 2021…

All you need to know about Hexaware Pre-IPO Shares!

We had first invested in Hexaware Pre-IPO Shares at around Rs. 470/share on Nov’2020 and since then here is how the price graph has moved of Hexaware Pre-IPO Shares: Jan 2021 – Rs. 525/share…

All you need to know about HDB Financials Pre-IPO Shares!

We had first invested in HDB Financials Pre-IPO Shares at around Rs. 225/share on Feb’2017 and since then here is how the price graph has moved: Jan 2019 – Rs. 325/share April 2020…

All you need to know about Sterlite Power Pre-IPO Shares!

We had first invested in Sterlite Power Pre-IPO shares at around Rs. 100/share on May'2018 and since then here is how the price graph has moved: December 2020 - Rs.…

Pros & Cons of investing in STUDDS Pre-IPO Shares.

Pros of Investing in STUDDS Pre-IPO Shares: 1. Promoters and management with prior experience: Mr. Madhu Khurana, Chairman and Managing Director of SAL, has approximately four decades of helmet industry…

All You Need To Know About Studds Pre-IPO Shares!

About the Company Studds Accessories Ltd (Studds), founded in 1973, is a renowned helmet manufacturer in India. Studds and SMK are two of the company's brands. SMK, a premium brand…

All you need to know about PharmEasy Pre-IPO shares

The pharmaceutical sector has always been as chaotic as we can imagine. Though we were all pleased with the wholesale and retail market structures provided by the pharmaceutical sector, the…

All you need to know about CSK Pre-IPO share price.

India Cements, the owner of the Chennai Super Kings, has seen CSK share price more than double in the last three months and double in the last two years. CSK…

Aricent Technologies- Merged with Capgemini

Aricent Technologies is a step-down subsidiary of Aricent (formerly known as the "Aricent Group") Aricent is a leading global engineering services and software company, with specialized expertise in the communications,…

API Holdings – PharmEasy listing price justified?

Pharma Industry Overview Indian pharma is a ~INR 2.1 trillion (~US$28 billion) opportunity and is projected to become ~INR 3.2 trillion (~US$43 billion) by 2025 (growing at ~9% CAGR), led…